xanthenes has been researched along with Acute Lung Injury in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Li, W; Pang, Y; Sun, H; Zhao, D | 1 |
Chen, N; Chi, G; Deng, Y; Feng, H; Hou, J; Soromou, LW; Wu, Q | 1 |
2 other study(ies) available for xanthenes and Acute Lung Injury
Article | Year |
---|---|
Structured triglyceride attenuates lung injury and inflammation in lipopolysaccharide‑induced acute lung injury by enhancing GPR120 expression.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cytokines; Inflammation; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Lung; Lung Injury; Male; MAP Kinase Kinase Kinases; Mice; Mice, Inbred C57BL; NF-kappa B; RAW 264.7 Cells; Receptors, G-Protein-Coupled; Sulfonamides; Triglycerides; Tumor Necrosis Factor-alpha; Xanthenes | 2021 |
Prime-O-glucosylcimifugin attenuates lipopolysaccharide-induced acute lung injury in mice.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cell Line; Cytokines; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Monosaccharides; NF-kappa B; Xanthenes | 2013 |